Phase I pancreatic cancer HSP trials in 1997, showed promising results despite some set-backs. HSP or heat-shock proteins are the caretakers of all protein and amino acid (peptide) sequences in the cell. If amino acid sequences and protein folding is out of place the heat-shock proteins fix the problem or have it removed from the cell. HSP assist in removing the foreign amino acid fragments from the cell to the immune system where T-cells decode the protein fragments. T-cells then rid the body of the unfamiliar peptides. Concerns from the previous pancreatic cancer HSP trial has been corrected and a Phase II pancreatic cancer HSP trial is currently underway. Read more...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment